DEP-HER2-zirconium

N/A

Report date: 2025/10/30 15:24:39

Base Information

Drug NameDEP-HER2-zirconium

Drug Alias NameDEP® HER2-zirconiumDEP-HER2-DFO-89ZrDEP-HER2-89Zr

ClassificationRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 binders

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesStarpharma Holdings Ltd

China Registration ClassN/A

Develop Information

Active CompaniesStarpharma Holdings Ltd

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A